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Abstract 
Xanthorrhizol is a sesquiterpenoid compound extracted from the rhizome of Curcuma 
xanthorrhiza. This study investigated the antiproliferative effect and the mechanism of action 
of xanthorrhizol on human hepatoma cells, HepG2, and the mode of cell death. An 
antiproliferative assay using methylene blue staining revealed that xanthorrhizol inhibited the 
proliferation of the HepG2 cells with a 50% inhibition of cell growth (IC50) value of 
4.17±0.053 μg/ml. The antiproliferative activity of xanthorrhizol was due to apoptosis 
induced in the HepG2 cells and not necrosis, which was confirmed by the Tdt-mediated 
dUTP nick end labeling (TUNEL) assay. The xanthorrhizol-treated HepG2 cells showed 
typical apoptotic morphology such as DNA fragmentation, cell shrinkage and elongated 
lamellipodia. The apoptosis mediated by xanthorrhizol in the HepG2 cells was associated 
with the activation of tumor suppressor p53 and down-regulation of antiapoptotic Bcl-2 
protein expression, but not Bax. The levels of Bcl-2 protein expression decreased 24-h after 
treatment with xanthorrhizol and remained lower than controls throughout the experiment, 
resulting in a shift in the Bax to Bcl-2 ratio thus favouring apoptosis. The processing of the 
initiator procaspase-9 was detected. Caspase-3 was also found to be activated, but not 
caspase-7. Xanthorrhizol exerts antiproliferative effects on HepG2 cells by inducing 
apoptosis via the mitochondrial pathway. 
 
Keyword: Xanthorrhizol, Curcuma xanthorrhiza, antiproliferative effect, apoptosis, p53,Bcl-
2 
  
 
